Naloxone (brand name Narcan) is a medication that reverses opioid overdose by competing with opioids for the same brain receptors. It works within two to three minutes when sprayed into the nose or injected into muscle, restoring breathing that has been suppressed by opioids including heroin, fentanyl, oxycodone, and methadone. Naloxone has no effect on people who do not have opioids in their system, has no abuse potential, and cannot cause harm if administered to someone who is not overdosing. It is available without a prescription in most countries and is the single most important tool in preventing opioid overdose death.
Understanding What Naloxone Does in the Brain
“I describe naloxone to families as a key that fits the same lock as the opioid but opens the door in the opposite direction,” says Dr. Ponlawat Pitsuwan, Physician at Phuket Island Rehab. “Opioids lock onto receptors in the brainstem and tell the breathing centre to slow down or stop. Naloxone arrives, pushes the opioid off the receptor, and tells the breathing centre to start working again. That is the entire mechanism, and it works the same way every time.”
To understand naloxone, it helps to understand how opioids cause overdose. Opioids bind to mu-opioid receptors, which are proteins on the surface of neurons throughout the brain and body. When an opioid molecule binds to a mu-receptor in the brainstem’s respiratory centre (the pre-Botzinger complex), it suppresses the rhythmic nerve signals that drive breathing. At therapeutic doses, this produces mild respiratory slowing. At overdose doses, it can suppress breathing entirely, leading to oxygen deprivation, brain damage, and death within minutes.
Naloxone is an opioid antagonist, meaning it binds to mu-opioid receptors without activating them. Think of it as a key that fits the lock but does not turn it. Because naloxone has a higher binding affinity than most opioids, it physically displaces the opioid molecules already sitting on the receptors. With the opioid displaced and naloxone occupying the receptor without suppressing breathing, the respiratory centre resumes normal function. The result is a rapid return of breathing, consciousness, and alertness.
Forms of Naloxone Available
Naloxone is available in two primary forms for bystander use, plus a third form used in hospital settings. Each is equally effective; the choice depends on availability, training, and the specific circumstances of the emergency.
| Form | Brand Name | How to Use | Onset | Advantages |
|---|---|---|---|---|
| Nasal spray | Narcan, Kloxxado | Insert nozzle into one nostril, press plunger | 2 to 3 minutes | No needles, no assembly, intuitive to use |
| Intramuscular injection | Generic naloxone with syringe | Inject into outer thigh or upper arm muscle | 2 to 5 minutes | Lower cost, available in more settings |
| Intravenous (hospital) | Generic naloxone IV | Administered by medical professional via IV line | 1 to 2 minutes | Fastest onset, precise dose titration |
The nasal spray is the most widely distributed form for community use because it requires no medical training, no needles, and no assembly. The device is pre-loaded: you remove it from the package, insert the tip into one nostril, and press the plunger. Each device delivers one dose. Kloxxado delivers a higher dose (8 mg vs Narcan’s 4 mg) designed specifically for the higher-potency fentanyl environment.
Step-by-Step: How to Use Narcan Nasal Spray
Using naloxone nasal spray is straightforward, but reviewing the steps before an emergency means you will not hesitate when seconds matter.
Lay the person on their back. Tilt the head back slightly to open the airway. Remove the naloxone spray from its packaging. Do not test or prime the device; the entire dose is needed. Insert the tip of the nozzle into one nostril until your fingers on either side of the nozzle touch the bottom of the person’s nose. Press the plunger firmly to release the dose. The entire contents will be delivered in a single spray.
After administration, watch for a response. Signs that naloxone is working include resumption or improvement of breathing, increased muscle tone (the person’s body becomes less limp), return of consciousness (the person may gasp, cough, or become agitated), and pupil dilation (pupils return from pinpoint to normal size). If there is no response within two to three minutes, administer a second dose in the other nostril.
Once the person responds, place them in the recovery position: on their side with the top knee bent forward and the top arm supporting the head. This prevents choking if they vomit, which is common. Stay with them and keep them awake. Do not allow them to use more opioids. Call emergency services if you have not already done so.
Critical Information: Naloxone Wears Off
This is the single most important fact that many people do not know about naloxone: its effects are temporary. Naloxone’s duration of action is 30 to 90 minutes. Many opioids, particularly fentanyl and methadone, last significantly longer. This means a person who has been revived with naloxone can re-enter overdose as the naloxone wears off and the opioid’s effects resume.
This is why calling emergency services is essential even when naloxone appears to have worked. The person needs medical monitoring for several hours after the overdose to ensure they do not re-enter respiratory depression. Leaving a naloxone-revived person alone because they “seem fine” is one of the most dangerous mistakes a bystander can make.
The Fentanyl Challenge
The rise of illicitly manufactured fentanyl has changed the naloxone landscape in two important ways. First, fentanyl’s extreme potency means that overdoses involve a very high concentration of opioid molecules occupying receptors. While standard naloxone doses (4 mg nasal) are usually sufficient, some fentanyl overdoses require two, three, or even four doses to achieve reversal. The recommendation is to carry at least two doses, preferably four.
Second, fentanyl analogues (carfentanil, acetylfentanyl, fluorofentanyl) vary in their receptor binding affinity, and some bind so tightly that naloxone must be administered in higher or repeated doses. Kloxxado’s 8 mg formulation was developed specifically to address this challenge. In hospital settings, naloxone can be administered intravenously with precise dose titration to overcome even the most potent fentanyl analogues.
Despite these challenges, naloxone remains effective against fentanyl. The mechanism is the same: competitive antagonism at the mu receptor. More drug on the receptor simply means more naloxone is needed to displace it. The solution is carrying more naloxone, not doubting that naloxone works.
Common Concerns and Misconceptions
Several misconceptions prevent people from carrying or using naloxone. The most common is the fear that administering naloxone will “make things worse” or harm the person. Naloxone cannot cause harm. In a person without opioids in their system, it has no effect whatsoever. In a person overdosing on opioids, it reverses the overdose. There is no scenario in which administering naloxone makes the situation worse than doing nothing.
Another concern is precipitated withdrawal. When naloxone rapidly displaces opioids from receptors in a dependent person, it triggers acute withdrawal symptoms: nausea, vomiting, agitation, tremor, sweating, and sometimes combativeness. This is unpleasant for the person and can be alarming for the bystander, but it is not life-threatening. The alternative to precipitated withdrawal is death from respiratory arrest. The person may be confused, frightened, or angry upon waking; explain calmly that they overdosed and you gave them medicine to save their life.
Some people worry about legal consequences of administering naloxone or calling emergency services during an overdose. Good Samaritan laws in many jurisdictions provide legal protection for people who call for help during a drug emergency. In the United States, all 50 states and the District of Columbia have some form of Good Samaritan protection. Similar protections exist in Canada, much of Europe, and Australia.
Who Should Carry Naloxone
Naloxone should be carried by anyone who uses opioids (prescription or illicit), anyone who lives with or regularly spends time with someone who uses opioids, anyone in recovery from opioid addiction (tolerance is reduced, making accidental overdose more dangerous), anyone who works in settings where opioid use or overdose may occur (shelters, harm reduction centres, nightlife venues), and first responders. Increasingly, public health agencies recommend that naloxone be as commonly carried as a first aid kit or fire extinguisher: available wherever an emergency might occur, even if the likelihood seems low.
When Opioid Use Has Become More Than Occasional
Carrying naloxone is a harm reduction measure that saves lives. It is not, however, a treatment for opioid addiction. If you or someone you know is using opioids regularly, if doses have escalated, if obtaining the drug has become a central preoccupation, or if withdrawal symptoms appear when use is interrupted, the pattern has moved beyond occasional use into dependence and possibly addiction. Comprehensive treatment at Phuket Island Rehab addresses opioid addiction through medically supervised withdrawal, medication-assisted treatment, individual and group therapy, and aftercare planning designed to support long-term recovery.
Summary
Naloxone is a simple, safe, effective medication that reverses opioid overdose by displacing opioid molecules from the brain’s mu-opioid receptors. It works within minutes, cannot cause harm, has no abuse potential, and is available without a prescription in most countries. In the current drug supply environment, where fentanyl contamination makes overdose unpredictable, carrying naloxone is a basic safety measure comparable to carrying an EpiPen for allergies or a fire extinguisher in a building.
“Naloxone gives the brain time,” says Dr. Ponlawat Pitsuwan. “It reverses the immediate crisis and restores breathing, creating a window for emergency medical care. It does not treat the addiction, but it preserves the one thing that makes treatment possible: a living patient. Every dose of naloxone that sits unused in a first aid kit is a success. Every dose administered to reverse an overdose is a life saved.”
Frequently Asked Questions
Can naloxone be used on children?
Yes. Naloxone is safe for use in children and infants experiencing opioid overdose. The nasal spray dose is the same (4 mg), though in very young children an injectable formulation allows more precise dosing. Accidental opioid exposure in children is a growing concern as fentanyl enters more environments, and paediatric naloxone use follows the same principle as adult use: administer immediately and call emergency services.
Does naloxone work on non-opioid drugs?
No. Naloxone only affects opioid receptors and has no effect on overdoses caused by stimulants (cocaine, methamphetamine), benzodiazepines (Xanax, Valium), alcohol, or other non-opioid substances. However, because fentanyl is increasingly found mixed with non-opioid drugs, it is worth administering naloxone in any suspected overdose where opioid involvement cannot be ruled out. If the overdose is non-opioid, naloxone will simply have no effect and cause no harm.
How should naloxone be stored?
Naloxone nasal spray should be stored at room temperature (15 to 25 degrees Celsius) in its sealed package until needed. It should not be refrigerated or frozen. It should be kept away from direct sunlight and extreme heat. Naloxone does degrade over time and has an expiration date, typically 18 to 24 months from manufacture. Expired naloxone is better than no naloxone: while potency may be slightly reduced, it is still worth administering in an emergency if no unexpired naloxone is available.
Will the person be angry at me for giving them naloxone?
Some people who are revived with naloxone experience precipitated withdrawal and may be confused, agitated, or angry. This is a physiological response, not a personal one. Most people, once they understand what happened, are grateful to be alive. The social discomfort of the immediate aftermath is a small price for saving a life. Do not let the possibility of an angry reaction prevent you from administering naloxone to someone who is not breathing.
How often does naloxone fail to reverse an overdose?
Naloxone failure to reverse a pure opioid overdose is rare when administered correctly and in sufficient doses. When naloxone appears not to work, the most common explanations are insufficient dose (particularly with high-potency fentanyl, requiring repeat doses), mixed substance overdose where a non-opioid drug is also contributing to respiratory depression, or the person has already experienced prolonged oxygen deprivation causing brain injury that naloxone cannot reverse. This last scenario underscores the importance of administering naloxone as quickly as possible.
Where can I get naloxone?
In the United States, naloxone is available without a prescription at most pharmacies. In the UK, it is available from pharmacies and through harm reduction services. In Australia, it is available over the counter. In Canada, it is free from many pharmacies and harm reduction organisations. In Thailand and other Southeast Asian countries, availability is expanding through public health programmes. Many organisations distribute naloxone for free through community programmes, needle exchanges, and harm reduction centres. Ask your local pharmacy or public health department about availability in your area.
Sources:
Substance Abuse and Mental Health Services Administration (2022). Naloxone. SAMHSA Opioid Overdose Prevention Toolkit.
World Health Organization (2023). Naloxone for management of opioid overdose in the community. WHO Model List of Essential Medicines.
Rzasa Lynn, R., & Galinkin, J. L. (2018). Naloxone dosage for opioid reversal: Current evidence and clinical implications. Therapeutic Advances in Drug Safety, 9(1), 63-88.
Naloxone, Narcan, Kloxxado, opioid antagonist, mu-opioid receptor, competitive antagonism, fentanyl, carfentanil, respiratory depression, pre-Botzinger complex, precipitated withdrawal, intranasal, intramuscular, intravenous, half-life, Good Samaritan law, harm reduction, opioid use disorder, medication-assisted treatment, buprenorphine, Phuket Island Rehab